Edition:
United States

Cerecor Inc (CERC.OQ)

CERC.OQ on NASDAQ Stock Exchange Capital Market

4.30USD
21 Sep 2018
Change (% chg)

$-0.42 (-8.90%)
Prev Close
$4.72
Open
$4.72
Day's High
$4.72
Day's Low
$4.30
Volume
62,215
Avg. Vol
13,752
52-wk High
$5.72
52-wk Low
$0.75

Chart for

About

Cerecor, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $145.53
Shares Outstanding(Mil.): 33.84
Dividend: --
Yield (%): --

Financials

  CERC.OQ Industry Sector
P/E (TTM): 8.01 108.33 32.69
EPS (TTM): 0.54 -- --
ROI: 33.44 1.50 12.72
ROE: 71.02 0.19 14.85

BRIEF-Cerecor Posts Q1 Loss Of $0.12 Per Share

* CERECOR - PROJECTS 2018 ADJUSTED EBITDA TO BE ABOUT BREAK-EVEN Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 11 2018

BRIEF-Cerecor Q4 Loss Per Share $0.11

* REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2017

Apr 02 2018

BRIEF-Cerecor Inc Appoints Peter Greenleaf CEO

* CERECOR APPOINTS PETER GREENLEAF AS CHIEF EXECUTIVE OFFICER

Mar 28 2018

Earnings vs. Estimates